Article
ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
Journal of neuroimmunology - 15 May 2013
Wagner Marta, Wiśniewski Andrzej, Bilińska Małgorzata, Pokryszko-Dragan Anna, Nowak Izabela, Kuśnierczyk Piotr, Jasek Monika
Abstract excerpt
Activated leukocyte cell adhesion molecule (ALCAM) is a molecule involved in leukocyte migration across the blood-brain barrier which is a key stage in multiple sclerosis (MS) pathogenesis. The present study is the first to report evidence of the association of rs6437585 ALCAM polymorphism with risk and progression of MS. Our investigation revealed that rs6437585CT individuals had higher risk of MS (OR=2.34;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
